Overview

The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment

Status:
Recruiting
Trial end date:
2030-12-01
Target enrollment:
Participant gender:
Summary
Efficacy of Ivermectin in larger doses in COVID-19 treatment
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Tanta University
Treatments:
Chloroquine
Chloroquine diphosphate
Ivermectin
Nitazoxanide